| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $178.7M | +2.0% |
| Cost of Revenue | $59.6M | -5.3% |
| Gross Profit | $119.1M | +6.1% |
| R&D Expense | $49.4M | -5.7% |
| SG&A Expense | $46.0M | -5.6% |
| Operating Income | -$24.1M | +37.7% |
| Pre-tax Income | -$23.7M | +36.8% |
| Income Tax | $7.7M | -14.2% |
| Net Income | -$31.3M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $33.1M | -9.9% |
| Short-term Investments | $48.3M | +47.7% |
| Accounts Receivable | $20.0M | -14.3% |
| Current Assets | $121.6M | +8.8% |
| Total Assets | $181.3M | -1.3% |
| Current Liabilities | $101.7M | +1.8% |
| Long-term Debt | $29.2M | -11.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $12.2M | +247.3% |
| Capital Expenditures | $521K | -80.0% |
| Investing Cash Flow | -$12.4M | -684.2% |
| Financing Cash Flow | -$3.5M | -3342.2% |
| Free Cash Flow | $11.7M | +207.4% |
| +32.5% |
| EPS (Basic) | -$0.21 | +38.2% |
| Total Liabilities |
| $156.9M |
| +2.3% |
| Stockholders' Equity | $24.4M | -19.6% |